Saved Results

No results saved yet.

Enter a patient name and hit Save on a result.

HCC Parallel Results Panel: six models, no combined stage

The Liver & HCC Parallel Results Panel reduces repeated data entry while keeping six models separate:

The panel reports each component's own status, source version, result, applicability, and trace. It does not calculate a consensus stage, agreement or discordance, maximum severity, treatment choice, prognosis, transplant candidacy, or allocation priority.

The public form now asks for 18 clinical inputs plus one scope confirmation instead of 32 separate questions. ECOG and its HCC attribution are combined; liver status and LT context are combined; and the three distinct adult MELD listing pathways remain explicit.

Why outputs may differ

These models answer different source questions and use different inputs. BCLC 2026 does not use Child-Pugh as a stage determinant, while original HKLC-9 requires an interpreted Child-Pugh class. Milan uses tumor burden, vascular invasion, and spread but is not a transplant-candidacy decision. Calculated MELD 3.0 is an OPTN policy equation and is not HCC staging.

Differences are therefore described as model-scope differences, not as agreement or disagreement.

Component-specific availability

The panel does not require every component to be interpretable before showing the others.

Calculation requires one concise scope confirmation covering adult established chronic liver disease, confirmed HCC at initial complete staging, contemporaneous unconfounded liver values, and calculated-MELD context. No favorable clinical determinant is silently defaulted.

Vascular definitions

Users enter intrahepatic venous invasion, extrahepatic vascular invasion, and extrahepatic spread once. The panel derives each model's source-specific fields:

Verification boundary

The compact public contract and unchanged engine passed 12,292 deterministic implementation assertions on 2026-07-30. This verifies software orchestration against independent source-locked oracles. It is not prospective or independent clinical validation and does not replace the actual source documents or individualized assessment.